NEW YORK (GenomeWeb) – Joshua LaBaer, executive director of Arizona State University's Biodesign Institute, is launching a company to commercialize his lab's Nucleic Acid Programmable Protein Array (NAPPA) technology.

Named Ordinatrix, the Phoenix, Arizona-based company will sell the NAPPA platform as a research tool and offer research services using the system, LaBaer said, noting that it plans to begin sales in July.

The company has appointed Jim Hauert, former executive at ADMA Biologics and Baxter Bioscience, as president and CEO, while LaBaer is a board member.